Skip to main content
. 2021 Jun 1;184(13):3467–3473.e11. doi: 10.1016/j.cell.2021.05.040

Figure S2.

Figure S2

NAb responses against SARS-CoV-2 variants, related to Figure 1

Pseudovirus neutralizing antibody (NAb) assays elicited by 1.125x1010 Ad26.COV2.S (n = 5) against the WA1/2020, D614G, B.1.1.7, and B.1.351 SARS-CoV-2 variants. Horizontal bars reflect geometric mean responses.